Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study.

Cell Oncol (Dordr) · 2016 · PMC5121180 · PMID 27613548

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

showed a trendp = 0.10so close (0.05 < p ≤ 0.1)

Patients with a high stroma percentage within the primary tumor showed a trend towards a worse OS in an univariate analysis; HR 1.84 (95 % CI 0.89–3.82), p = 0.10, with a 5 year survival rate of 84 % versus 62 % in those with a low stroma percentage (Fig. 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.